Key facts
Company highlights
With 95,000+ people across 150 countries, we put patients first — delivering innovative solutions that treat more than 70 health conditions, from advanced cardiac and neurovascular care to robotic-assisted surgery. Our health tech improves the lives of two people every second. In everything we do, we are engineering the extraordinary.
174+
active clinical trials
$103.4M
donated by Medtronic and the Medtronic Foundation
$2.7B
in R&D investments
41K+
active patent matters
Information reflects FY25 data
Therapies and services for insulin-dependent people who have Type 1 and Type 2 diabetes
Surgical
Endoscopy
Acute Care and Monitoring
Cranial and Spinal Technologies
Neuromodulation
Neurovascular
Pelvic Health and Gastric Therapies
Ear, Nose, and Throat
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.